Medication Assisted Treatment, or "MAT" for short, is the use of FDA approved medication for the treatment of opiate/opioid addiction and substance abuse with counseling and behavioral therapies to treat addiction (Cormier, 2014). This treatment can be used concurrently with a 12-step addiction program. Common medications used with this treatment are Methadone, Buprenorphine, Naltrexone, Acamprosate and Disulfiram. Despite research demonstrating MAT’s effectiveness as an evidence-based practice, such treatment remains underutilized (Reardon, 2014). For example, less than one-half of the 2.5 million Americans aged 12 or older who abused or were dependent on opioids in 2013 received MAT with positive effects (Volkow, Frieden, Hyde, & Cha, 2014). Training on MAT needs to be expanded to providers to aid in decreasing the rate of overdose and abuse. The Substance Abuse and Mental Health Services Administration (SAMHSA) provides in depth detail as to where providers can receive this certification along with information on regulations and guidelines of the program. Oversight of treatment medications used in MAT remains a multilateral system involving states, SAMHSA, the Department of Health and Human Services (HHS), the Department of Justice (DOJ), and DEA (Legislation, Regulations, and Guidelines,